FDA Physician Labeling Rule Withdrawn From OMB

Final rule has drawn opposition from industry, especially the addition of a "highlights" section. FDA is proposing staggered implementation to lower the costs of the labeling redesign. Rule would also affect DTC ads. Office of Management & Budget received the reg in January.